Spencer et al., 1967 - Google Patents
Inhibition of radiostrontium absorption in manSpencer et al., 1967
- Document ID
- 13061339788677432992
- Author
- Spencer H
- Lewin I
- Samachson J
- Publication year
- Publication venue
- The International Journal of Applied Radiation and Isotopes
External Links
Snippet
The ingestion of aluminum phosphate gel with breakfast caused an average 87 per cent decrease of the intestinal absorption of radiostrontium in man as judged by two different criteria: the marked decrease in the Sr 85 plasma levels and the increase in the fecal Sr 85 …
- 241000282414 Homo sapiens 0 title abstract description 10
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/853—Decongestant
- Y10S514/855—Expectorant
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/899—Menstrual disorder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/867—Diarrhea
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Spencer et al. | Strontium 85 and calcium 45 metabolism in man | |
| Wajchenberg et al. | Effect of dexamethasone on calcium metabolism and 47Ca kinetics in normal subjects | |
| Hursh et al. | Absorption of 212Pb from the gastrointestinal tract of man | |
| Robinson et al. | Iodine-131 in breast milk following therapy for thyroid carcinoma | |
| BELL et al. | Pseudohypoparathyroidism with osteitis fibrosa cystica and impaired absorption of calcium | |
| Spencer et al. | Influence of dietary calcium intake on Ca47 absorption in man | |
| RABINOWITZ et al. | Comparative tissue absorption of oral 14C‐aspirin and topical triethanolamine 14C‐salicylate in human and canine knee joints | |
| Castronovo et al. | Comparative toxicity and pharmacodynamics of ionic indium chloride and hydrated indium oxide | |
| Ehrig et al. | Effect of long-term thiazide therapy on intestinal calcium absorption in patients with recurrent renal calculi | |
| Fujita et al. | Increase of bone mineral density by calcium supplement with oyster shell electrolysate | |
| HURWITZ et al. | The effects of antacids on the absorption of orally administered pentobarbital in the rat | |
| Winter et al. | Somatomedin activity in the Mauriac syndrome | |
| Harrison et al. | The effect of sodium alginate on the absorption of strontium and calcium in human subjects | |
| Knutsen et al. | Intravenous theophylline-induced excretion of calcium, magnesium and sodium in patients with recurrent asthmatic attacks | |
| Waldron-Edward et al. | Studies on the inhibition of intestinal absorption of radioactive strontium: III. The effect of administration of sodium alginate in food and in drinking water | |
| Schulman et al. | Studies on the Metabolism of Thiourea: I. Distribution and Excretion in the Rat of Thiourea Labeled with Radioactive Sulfur | |
| Spencer et al. | Effect of aluminum hydroxide on plasma fluoride and fluoride excretion during a high fluoride intake in man | |
| Spencer et al. | Inhibition of radiostrontium absorption in man | |
| Barnes et al. | Comparison of the plasma concentration and urinary excretion of strontium and calcium in man | |
| Travis et al. | Defective thirst mechanism secondary to a hypothalamic lesion: Studies in a child with adipsia, polyphagia, obesity, and persistent hyperosmolality | |
| HENDRIX | Abnormal skeletal mineral metabolism in sarcoidosis | |
| Weitzman et al. | Hyperosmolarity associated with a hypothalamic lesion | |
| Martz et al. | Use of a combination of anion and cation exchange resins in the treatment of edema and ascites | |
| Harden et al. | Recent Advances in the Diagnosis of Endocrine Disease: The Salivary Iodide Trap in Man: Clinical Applications | |
| JACKSON et al. | Concomitant hyperparathyroidism as a cause of the hypercalcemia associated with hyperthyroidism |